Target Poor or Non Binder(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T01597 | Target Info | |||
Target Name | Catalase (CAT) | ||||
Synonyms |
Human catalase
Click to Show/Hide
|
||||
Target Type | Clinical trial Target | ||||
Gene Name | CAT | ||||
Biochemical Class | Peroxide acceptor oxidoreductase | ||||
UniProt ID |
Poor Binders of This Target (in total, 2 binders) | Download | Top | |||
---|---|---|---|---|---|
Compound Name |
O-[(4-Iodophenyl)methyl]hydroxylamine;hydrochloride
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL3763688; BDBM50146460
Click to Show/Hide
|
||||
Activity |
IC50 ~ 100000 nM
|
[1] | |||
Compound Name |
O-(m-Chlorobenzyl)hydroxylamine hydrochloride
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
1-[(Aminooxy)methyl]-3-chlorobenzene hydrochloride; O-(3-Chlorobenzyl)hydroxylamine hydrochloride; O-[(3-chlorophenyl)methyl]hydroxylamine hydrochloride; O-[(3-chlorophenyl)methyl]hydroxylamine;hydrochloride; CHEMBL3765807; Hydroxylamine, O-(m-chlorobenzyl)-, hydrochloride; 1-[(AMMONIOOXY)METHYL]-3-CHLOROBENZENECHLORIDE; SCHEMBL1715226; KS-00001QLL; DTXSID50952080; Hydroxylamine, O-[(3-chlorophenyl)methyl]-, hydrochloride; BDBM50146461; MFCD01114569; NSC131325; SBB091672; AKOS005069166; AM90372; NSC-131325; FT-0679910; C-4165; 10F-930; J-523796; 1-[(Ammoniooxy)methyl]-3-chlorobenzene hydrochloride; 1-[(ammoniooxy)methyl]-3-chlorobenzenechloride, AldrichCPR; Hydroxylamine,o-[(3-chlorophenyl)methyl]-,hydrochloride(1:1); Hydroxylamine, O-[(3-chlorophenyl)methyl]-, hydrochloride (1:1); O-[(3-Chlorophenyl)methyl]hydroxylamine--hydrogen chloride (1/1)
Click to Show/Hide
|
||||
Activity |
IC50 ~ 100000 nM
|
[1] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | O-alkylhydroxylamines as rationally-designed mechanism-based inhibitors of indoleamine 2,3-dioxygenase-1. Eur J Med Chem. 2016 Jan 27;108:564-576. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.